MedPath

Evaluation the efficasy of Boswellia serrata on patients with mild to moderate Alzheimer disease

Not Applicable
Conditions
patients with mild to moderate Alzheimer.
Alzheimer disease, unspecified
Registration Number
IRCT2015051822306N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

mild to moderate Alzheimer disease patients
Exclusion criteria: parkinson; multiple sclorosis; heart failure stage C and D of AHA/ACC classification; ischemic heart disease; uncontrolled hypertension; schizophrenia; active peptic ulcer; uncontrolled diabetes and alcohol abuse.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Memory. Timepoint: at the first and every month up to 3 months. Method of measurement: CDR (clinical dementia rating).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath